[2] Long-term follow-up: Once stable on maintenance therapy, routine blood monitoring is not usually necessary unless new symptoms develop
[31] [32] Patients with type 2 diabetes taking tirzepatide often have multiple overlapping risk factors, including advanced age, metformin use, and potential dietary restrictions, making them a particularly vulnerable population requiring vigilant monitoring
Different areas have different tissue depths, nerve densities, and proximity to blood vessels
[DOI] [PMC free article] [PubMed] [Google Scholar] 87.Mehta A., Motavaf M., Raza D., McLure A.J., Osei-Opare K.D., Bordone L.A., Gru A.A
ISBN 978-1-61035-065-5